NCT03473262View on ClinicalTrials.gov

Empagliflozin-based Quadruple Combination vs Insulin Glarine-based Combination Therapy in Patients With Type 2 Diabetes

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

July 18, 2018

Study Completion Date

July 18, 2018

Conditions
Diabetes Mellitus, Type 2
All Listed Sponsors
lead

Chungbuk National University Hospital

OTHER

NCT03473262 - Empagliflozin-based Quadruple Combination vs Insulin Glarine-based Combination Therapy in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter